Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hepatitis × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 215 Lymphoma, Large B-Cell, Diffuse 159 Lymphoma 156 Precursor Cell Lymphoblastic Leukemia-Lymphoma 75 Lymphoma, Follicular 73 Lymphoma, Non-Hodgkin 66 Burkitt Lymphoma 63 Multiple Myeloma 56 Leukemia 51 Hodgkin Disease 41 Lymphoma, Mantle-Cell 37 Neoplasms 31 Lymphoma, T-Cell, Peripheral 29 Lymphoma, B-Cell 27 Lymphoma, B-Cell, Marginal Zone 26 Lymphoma, Large-Cell, Immunoblastic 24 Lymphoma, Large-Cell, Anaplastic 24 Neoplasm Metastasis 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Neoplasms, Plasma Cell 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19 Recurrence 15 Dendritic Cell Sarcoma, Interdigitating 14 Immunoblastic Lymphadenopathy 13 Lymphoma, T-Cell 9 Waldenstrom Macroglobulinemia 8 Primary Myelofibrosis 8 Myelodysplastic Syndromes 8 Leukemia, Biphenotypic, Acute 8 Blast Crisis 8

Interventions

bavituximab 1 Ursodeoxycholic Acid 1 Steroids 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡